NYSE:RNR - RenaissanceRe Stock Price, News, & Analysis

RenaissanceRe trades on the New York Stock Exchange (NYSE) under the ticker symbol "RNR."

RenaissanceRe declared a quarterly dividend on Thursday, February 7th. Investors of record on Friday, March 15th will be paid a dividend of $0.34 per share on Friday, March 29th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.94%. The ex-dividend date of this dividend is Thursday, March 14th. This is a positive change from RenaissanceRe's previous quarterly dividend of $0.33. View RenaissanceRe's Dividend History.

RenaissanceRe announced that its Board of Directors has authorized a stock buyback program on Monday, November 13th 2017, which permits the company to buyback $500,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to reacquire shares of its stock through open market purchases. Shares buyback programs are often a sign that the company's leadership believes its stock is undervalued.

RenaissanceRe Holdings Ltd. (NYSE:RNR) issued its quarterly earnings results on Tuesday, January, 29th. The insurance provider reported $0.02 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($1.93) by $1.95. The insurance provider earned $633.44 million during the quarter, compared to analyst estimates of $545.60 million. RenaissanceRe had a return on equity of 9.18% and a net margin of 10.96%. View RenaissanceRe's Earnings History.

RenaissanceRe is scheduled to release their next quarterly earnings announcement on Tuesday, May 7th 2019. View Earnings Estimates for RenaissanceRe.

9 Wall Street analysts have issued 12-month price targets for RenaissanceRe's stock. Their predictions range from $125.00 to $168.00. On average, they anticipate RenaissanceRe's stock price to reach $143.5556 in the next twelve months. This suggests that the stock has a possible downside of 0.3%. View Analyst Price Targets for RenaissanceRe.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RenaissanceRe in the last year. There are currently 2 sell ratings, 4 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for RenaissanceRe.

News articles about RNR stock have trended somewhat positive this week, InfoTrie reports. The research firm scores the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. RenaissanceRe earned a news sentiment score of 1.0 on InfoTrie's scale. They also gave media coverage about the insurance provider a news buzz of 2.0 out of 10, meaning that recent media coverage is very unlikely to have an impact on the stock's share price in the near future.

Some companies that are related to RenaissanceRe include Ms&Ad Insurance Group (MSADY), Hartford Financial Services Group (HIG), Loews (L), Markel (MKL), Cincinnati Financial (CINF), Fairfax Financial Holdings Ltd Subordinate Voting Shares (FRFHF), Arch Capital Group (ACGL), Cna Financial (CNA), W. R. Berkley (WRB), Alleghany (Y), Everest Re Group (RE), American Financial Group (AFG), Kemper (KMPR), Hanover Insurance Group (THG) and Axis Capital (AXS).

Based on aggregate information from My MarketBeat watchlists, some companies that other RenaissanceRe investors own include Exxon Mobil (XOM), Medtronic (MDT), Advanced Micro Devices (AMD), Micron Technology (MU), Walmart (WMT), Terex (TEX), United States Steel (X), Baxter International (BAX), Yum! Brands (YUM) and AAR (AIR).

RenaissanceRe's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (12.17%), Boston Partners (3.33%), Lord Abbett & CO. LLC (1.86%), Dimensional Fund Advisors LP (1.84%), Victory Capital Management Inc. (1.78%) and Polar Capital LLP (1.23%). Company insiders that own RenaissanceRe stock include Henry Klehm III, Jonathan Paradine, Kevin Odonnell, Ross Curtis, Sean G Brosnan and Stephen Howard Weinstein. View Institutional Ownership Trends for RenaissanceRe.

RNR stock was sold by a variety of institutional investors in the last quarter, including Royal London Asset Management Ltd., ARGA Investment Management LP, Bessemer Group Inc., Los Angeles Capital Management & Equity Research Inc., Monarch Partners Asset Management LLC, Lord Abbett & CO. LLC, Dimensional Fund Advisors LP and Millennium Management LLC. Company insiders that have sold RenaissanceRe company stock in the last year include Henry Klehm III, Jonathan Paradine and Sean G Brosnan. View Insider Buying and Selling for RenaissanceRe.

RNR stock was acquired by a variety of institutional investors in the last quarter, including Boston Partners, Diamond Hill Capital Management Inc., BlackRock Inc., Philadelphia Financial Management of San Francisco LLC, California Public Employees Retirement System, Geode Capital Management LLC, Westpac Banking Corp and Rhumbline Advisers. View Insider Buying and Selling for RenaissanceRe.

Shares of RNR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of RNR stock can currently be purchased for approximately $144.05.

RenaissanceRe has a market capitalization of $6.08 billion and generates $2.07 billion in revenue each year. The insurance provider earns $227.36 million in net income (profit) each year or $9.17 on an earnings per share basis. RenaissanceRe employs 411 workers across the globe.

The official website for RenaissanceRe is http://www.renre.com.

RenaissanceRe's mailing address is RENAISSANCE HOUSE 12 CROW LANE, PEMBROKE D0, HM 19. The insurance provider can be reached via phone at 441-295-4513 or via email at [email protected]